Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04268069 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye
A Phase 2 study, sponsored by ORA.
- Completed
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
NCT04268069 is a Phase 2 study that has completed, run by ORA. The registered enrollment target is 160 participants.
The verdict
NCT04268069, a Phase 2 study, has completed, sponsored by ORA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
Study Summary
Evaluation of safety and efficacy of PL9643 Ophthalmic Solution compared to placebo for the treatment of the signs and symptoms of dry eye.
Interventions
- DRUG Placebo Ophthalmic Solution
- DRUG PL9643 Ophthalmic Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2020-02-14 |
| Est. Completion | 2020-10-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04268069
The ClinicalTrials.gov registry entry for NCT04268069 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ORA, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Ophthalmic Solution is the first listed.
NCT04268069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04268069 about?
NCT04268069 is a clinical study titled "Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye". Evaluation of safety and efficacy of PL9643 Ophthalmic Solution compared to placebo for the treatment of the signs and symptoms of dry eye.
What is the current status of trial NCT04268069?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2020-02-14. Estimated completion is 2020-10-05.
What interventions are being tested in trial NCT04268069?
The interventions under investigation include: Placebo Ophthalmic Solution (DRUG), PL9643 Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT04268069?
This trial is sponsored by ORA, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.